glp-1 bacteria Not Working? Your Gut Microbiome May Be the Reason 🧬 Did you know your

Understanding why your GLP-1 therapy may not be delivering anticipated results is essential for working with your healthcare team to optimise treatment outcomes and achieve your therapeutic goals

Meta-analyses show GLP-1 receptor agonists can reduce inflammatory biomarkers, including CRP , with improvements also reported across other inflammatory and oxidative stress measures in studied populations., Why this matters: Lowering metabolic inflammation overlaps with meaningful improvements in long-term health risk pathways, including cardiometabolic risk and metabolic organ stresseven if patients dont feel inflammation improving day to day., 2) They Improve Liver Inflammation ( NAFLD / MASH ) Semaglutide and tirzepatide show some of the strongest evidence for metabolically driven liver disease

Will my dosing frequency change once I reach my goal weight

Weekly subcutaneous injections of tirzepatide show promise in treating both type 2 diabetes and cardiometabolic disorders

Dietary Strategies to Minimize Gas While on Semaglutide The most effective approach to reducing gas is consuming smaller, more frequent meals that are easier for your slowed stomach to process

Some people need insulin